- Home
- HE vs NNNN Comparison
HE vs NNNN Comparison
Compare HE & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HE
- NNNN
- Stock Information
- Founded
- HE 1891
- NNNN 2021
- Country
- HE United States
- NNNN Germany
- Employees
- HE N/A
- NNNN N/A
- Industry
- HE Electric Utilities: Central
- NNNN Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- HE Utilities
- NNNN Health Care
- Exchange
- HE Nasdaq
- NNNN Nasdaq
- Market Cap
- HE 1.9B
- NNNN 2.2B
- IPO Year
- HE N/A
- NNNN 2025
- Fundamental
- Price
- HE $11.28
- NNNN $28.64
- Analyst Decision
- HE Hold
- NNNN
- Analyst Count
- HE 4
- NNNN 0
- Target Price
- HE $10.94
- NNNN N/A
- AVG Volume (30 Days)
- HE 1.7M
- NNNN 80.4K
- Earning Date
- HE 11-07-2025
- NNNN 10-27-2025
- Dividend Yield
- HE N/A
- NNNN N/A
- EPS Growth
- HE N/A
- NNNN N/A
- EPS
- HE N/A
- NNNN 0.06
- Revenue
- HE $3,122,881,000.00
- NNNN $8,185,146.00
- Revenue This Year
- HE $12.58
- NNNN N/A
- Revenue Next Year
- HE $2.10
- NNNN N/A
- P/E Ratio
- HE N/A
- NNNN $537.35
- Revenue Growth
- HE 2.36
- NNNN 21.95
- 52 Week Low
- HE $8.14
- NNNN $5.18
- 52 Week High
- HE $13.41
- NNNN $55.65
- Technical
- Relative Strength Index (RSI)
- HE 47.65
- NNNN 37.86
- Support Level
- HE $10.79
- NNNN $26.05
- Resistance Level
- HE $11.46
- NNNN $30.72
- Average True Range (ATR)
- HE 0.23
- NNNN 5.63
- MACD
- HE 0.02
- NNNN -0.04
- Stochastic Oscillator
- HE 72.39
- NNNN 18.87
About HE Hawaiian Electric Industries Inc.
Hawaiian Electric Industries is the parent company of three Hawaii-based regulated utilities and owns a 10% minority interest in Hawaii's American Savings Bank. The utilities provide electricity on the five islands of Oahu, Hawaii, Maui, Molokai, and Lanai.
About NNNN Anbio Biotechnology Class A Ordinary Shares
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.